Jianhua Rao

Academy of Medical Sciences — United Kingdom

Medicine · Health Sciences

30h-index2.5kcitations115works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Organ Transplantation Techniques and Outcomes(22), Liver Disease Diagnosis and Treatment(18), Liver Disease and Transplantation(13), Liver physiology and pathology(13), Hippo pathway signaling and YAP/TAZ(11)

Publications115 total

APE1 mediates chemoresistance in esophageal squamous cell carcinoma by remodeling the immunosuppressive microenvironment
Frontiers in Immunology·2025Open Access
Ceritinib–ibuprofen synergistic hepatotoxicity: Insights from real-world data and liver organoid models
Toxicology·2025· 1 cited
YAP ameliorates CCl4-induced acute liver injury by activating autophagy via modulating p300/CBP-mediated FoxO3 acetylation
International Immunopharmacology·2025Open Access
Macrophage Nogo-B Drives Liver Fibrosis
Cellular and Molecular Gastroenterology and Hepatology·2025Open Access
Macrophage Signaling Pathways in Health and Disease: From Bench to Bedside Applications
MedComm·2025· 17 citedOpen Access
Development of an AI model for DILI-level prediction using liver organoid brightfield images
Communications Biology·2025· 6 citedOpen Access
Donafenib combined with capecitabine for postoperative adjuvant therapy of biliary malignant tumors with high risk of recurrence: A multi-center, randomized controlled, phase II study.
Journal of Clinical Oncology·2025
The efficacy and safety of donafenib as postoperative adjuvant therapy in patients at high risk of recurrence following radical resection of hepatocellular carcinoma (HCC): A multicenter retrospective study.
Journal of Clinical Oncology·2025
NEO-ERA-01: A multi-center, single-arm, phase II study with neoadjuvant therapy of HAIC (GEMOX) combined with adebrelimab and lenvatinib for resectable intrahepatic cholangiocarcinoma with high-risk recurrence factors.
Journal of Clinical Oncology·2025
THU-095 Single-cell spatial proteomic landscape of intrahepatic cholangiocarcinoma immune microenvironment reveals immune evasion via FSTL1negative macrophage
Journal of Hepatology·2025
WED-475 Plasma FSTL-1 accurately assesses MASH-associated liver fibrosis stage
Journal of Hepatology·2025
Novel system for organ preservation in liver transplantation: Feed macrophages with ceria nanoparticles
Chinese Medical Journal·2025Open Access
Adrenomedullin Inhibits the Efficacy of Combined Immunotherapy and Targeted Therapy in Biliary Tract Cancer by Disrupting Endothelial Cell Functions
Journal of Cellular and Molecular Medicine·2025· 4 citedOpen Access
Yap Ameliorates Ccl4-Induced Acute Liver Injury by Activating Autophagy Via Modulating P300/Cbp-Mediated Foxo3 Acetylation
SSRN Electronic Journal·2025Open Access
Reply: Can plasma FSTL-1 levels serve as a reliable biomarker for advanced fibrosis?
Hepatology·2024
Plasma FSTL-1 as a noninvasive diagnostic biomarker for patients with advanced liver fibrosis
Hepatology·2024· 12 citedOpen Access
A simulation study on the sub-threshold joint gravitational wave-electromagnetic wave observation on binary neutron star mergers
Monthly Notices of the Royal Astronomical Society·2024· 2 citedOpen Access
[Efficacy and Safety of Ixazomib Combined with Thalidomide and Dexamethasone in Treatment of Multiple Myeloma].
PubMed·2024
261.12: Novel system for organ preservation: Feed macrophages Ceria nanoparticles.
Transplantation·2024
264.7: Macrophage nogo-B facilitates liver fibrosis.
Transplantation·2024
page 1 of 6Next →

Frequent Co-authors

Xuehao Wang(26), Feng Cheng(17), Ling Lü(16), Shikun Yang(12), Ling Lü(8), Yuanchang Hu(8), Jiannan Qiu(7), Ling Lu(7), Wenjie Yang(7), Xiongxiong Pan(6), Yuan Zhai(6), Chao Yang(6), Xiaofeng Qian(6), Ming Ni(5), Haoming Zhou(5), Yongxiang Xia(5), Xinzheng Dai(5), Feng Zhang(4), Shi Yue(3), Ronald W. Busuttil(3)